12/21
Headlines

Mark DeFrance

Mark DeFrance is a senior research analyst at Tech Insider, focusing on the enterprise software sector. Prior to joining TI, Mark covered enterprise software for First Albany, and prior to that he worked in equity research at B.T. Alex Brown and Bankers Trust. Mark has written software applications in various programming languages including BASIC, Pascal, and COBOL. He has also been recognized in The Wall Street Journal's "Best on the Street" survey and was recognized by Forbes Magazine as the No. 1 sell-side stock picker in the software industry for a five-year period, with returns of 115% versus 26% for the software industry.

Bluebirdbio BLUE NASDAQ BLUE

Healthcare Gainers: Gentiva Health Services (NASDAQ:GTIV), bluebird bio Inc (NASDAQ:BLUE), Celldex Therapeutics (NASDAQ:CLDX), Intercept Pharmaceuticals (NASDAQ:ICPT), Northwest Biotherapeutics (NASDAQ:NWBO)

Mark DeFrance04 mins

Gentiva Health Services Inc. (NASDAQ:GTIV)’s rejection of the takeover proposal from Kindred Healthcare Inc. ( KND ) is hitting headlines and drawing investor attention to the healthcare space. Gentiva Health Services, Inc. (NASDAQ:GTIV) stock performance was -1.52% in last session and finished the day at $13.62. Traded volume was 1.47million shares in the last session…

Read More
CSCO NASDAQ CSCO Cisco Systems

Hot Movers: Cisco Systems (NASDAQ:CSCO), Pfizer Inc. (NYSE:PFE), World Wrestling Entertainment (NYSE:WWE), J.C. Penney Company (NYSE:JCP), Verizon Communications Inc. (NYSE:VZ)

Mark DeFrance03 mins

Cisco Systems, Inc. (NASDAQ:CSCO) recently named Marco Inc. its 2013 Central Area Small to Medium Business Partner of the Year for leadership in implementing unified communications and cloud networking systems among other Cisco Systems, Inc. (NASDAQ:CSCO) technologies. Cisco Systems, Inc. (NASDAQ:CSCO) stock performance was 0.79% in last session and finished the day at $24.37. Traded…

Read More

NASDAQ Bearish STocks: G&K Services (NASDAQ:GK), Corinthian Colleges (NASDAQ:COCO), Guanwei Recycling (NASDAQ:GPRC), Xoom Corp (NASDAQ:XOOM), Hanwha Solarone (NASDAQ:HSOL)

Mark DeFrance04 mins

G&K Services Inc (NASDAQ:GK) was upgraded by equities research analysts at Sidoti from a “neutral” rating to a “buy” rating in a research note issued to investors on Friday,TheFlyOnTheWall.com reports.Analysts at Robert W. Baird downgraded shares of G & K Services from an “outperform” rating to a “neutral” rating in a research note on Thursday,…

Read More
Gilead Sciences GILD NASDAQ:GILD

Healthcare Losers: Bristol-Myers Squibb (NYSE:BMY), LDR Holding Corp (NASDAQ:LDRH), Vanda Pharmaceuticals (NASDAQ:VNDA), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Mark DeFrance03 mins

Bristol-Myers Squibb Co (NYSE:BMY) and Urban Outfitters (URBN) retreated 6.1 percent and 3.6 percent respectively, after brokers lowered their ratings on these stocks. Weaker-than-expected first-quarter results and dismal second-quarter earnings guidance led Wal-Mart Stores (WMT) to drop 2.4 per cent. Bristol-Myers Squibb Co (NYSE:BMY) stock performance was -6.12% in last session and finished the day…

Read More

Biotech Bullish Stocks: ImmuCell Corporation (NASDAQ:ICCC), TG Therapeutics, Inc. (NASDAQ:TGTX), Relypsa Inc (NASDAQ:RLYP), OHR Pharmaceutical Inc (NASDAQ:OHRP)

Mark DeFrance02 mins

ImmuCell Corporation (NASDAQ:ICCC), a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, today announced financial results for its first quarter ended March 31, 2014. For the first quarter ended March 31, 2014, ImmuCell Corporation (NASDAQ:ICCC) reported a product sales increase…

Read More

Biotech Losers: Insys Therapeutics Inc (NASDAQ:INSY), Enzymotec Ltd (NASDAQ:ENZY), Geron Corporation (NASDAQ:GERN), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

Mark DeFrance03 mins

Insys Therapeutics, Inc. (NASDAQ:INSY)’s shares have been under pressure recently on news regarding prescribing patterns for Subsys. The stock price of the company tumbled 17.41% and 15.45% in the last two consecutive trading sessions. Insys Therapeutics Inc (NASDAQ:INSY) stock performance was -15.70% in last session and finished the day at $23.01. Traded volume was 3.24million…

Read More